Maraganore Johninsider trades
In SEC Form 4 filings, Maraganore John is listed as Director of Rapport Therapeutics, Inc. (RAPP) and Director of City Therapeutics, Inc. (CTY). In the last 90 days, Maraganore John bought $248.9K of Rapport Therapeutics, Inc. (RAPP) on the open market and sold none. The largest purchase was $217.3K of Rapport Therapeutics, Inc. (RAPP) on Oct 22. Took part in a cluster buy; the latest at Rapport Therapeutics, Inc. (RAPP), where 6 insiders bought within 3 days, ending Oct 23.
Companies and roles
Cluster buys
- RAPP: 6 insiders bought $1.66M between Oct 21 – Oct 23.
Form 4 historysince 2026-10-19
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| RAPPRapport Therapeutics, Inc. | Oct 22 | Oct 22 | P | 8,239 | $26.38 | Purchase +$217,344 | 8,239 | No | Form 4 |
| RAPPRapport Therapeutics, Inc. | Oct 22 | Oct 22 | P | 1,172 | $26.92 | Purchase +$31,547 | 9,411 | No | Form 4 |
| CTYCity Therapeutics, Inc. | Oct 19 | Oct 19 | C | 610,759 | not reported | not reported | 1,470,692 | No | Form 4 |
| CTYCity Therapeutics, Inc. | Oct 19 | Oct 19 | C · derivative | 500,000 | $0.00 | $0 | not reported | No | Form 4 |
| CTYCity Therapeutics, Inc. | Oct 19 | Oct 19 | C · derivative | 56,095 | $0.00 | $0 | not reported | No | Form 4 |
| CTYCity Therapeutics, Inc. | Oct 15 | Oct 19 | A · derivative | 22,649 | $18.00 | $407,682 | 22,649 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.